Prediction Case File
YouTubeEvaluation Complete

Book Your Free Portfolio Review Call: https://felixfriends.org/review

3 extracted signals · 3 resolved · 0 still active

Felix & Friends (Goat Academy) profile imageFelix & Friends (Goat Academy)19 Aug 2025, 17:00 UTC
Video preview for Book Your Free Portfolio Review Call: https://felixfriends.org/review
Signals
3
Eligible signals in this source
Open
0
Still being tracked
Resolved
3
Evaluable outcomes
Successful
2
Canonical correct result
Failed
1
Canonical failed result
Resolved success
66.67%
Open and excluded signals omitted
Source overview

AI-generated source summary

This video provides a market analysis that discusses three stock symbols: XHB, XBI, and ABBV. XHB is showing laggard tendencies, and may benefit from lower interest rates. The security is trading at 113.14. The XBI, biotech ETF, has been consolidating sideways and may be positioned for an upward breakout after three years of stagnation. The third ticker is ABBV, and the analyst emphasizes the security's consolidated movement and has a similar pattern to XBI.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    3 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Felix & Friends (Goat Academy)

Tracked signals
338
Historical success
59.2%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.